App. 100 million in cash....very, very high institutional and insider ownership..... A bio tech with 2 approved drugs and revenue, rare among that breed....... share price trading 35 per cent off 52 week high......Was picked by many, including myself, as the bio tech to be number one in share price gain for 2013.....Up big on a very red day for stocks, esp. bio techs...... Cash on hand itself close to share price value...If one is not an owner of this one, may be prudent to buy on open in A.M.
I agree with many of your stated facts and your sentiment. I have only owned this since early March, purchasing my first lot at 2.04 and averaged up as I added to 2.18. Who besides yourself called it to be among 2013's best performing biotechs?
jrdelane, you sure had some great timing. If you nitice, the stock was higher than when you bought on Jan. 1, and made a nice Jan. run, only to fall back when you bought. As for who else, it was back at the first of the year, when lots were making predictions, I recall it getting some mention but do not recall who from. However, I do think you realize it could be one of the big winners of 2013, it has credentials, a little exposure would help.